← Back to Screener
Inogen Inc (INGN)
Price$6.59
Favorite Metrics
Price vs S&P 500 (26W)-32.64%
Price vs S&P 500 (4W)-4.68%
Market Capitalization$168.84M
All Metrics
P/CF (Annual)29.56x
Book Value / Share (Quarterly)$7.06
P/TBV (Annual)1.13x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-2.59%
Cash Flow / Share (Quarterly)$-0.79
Price vs S&P 500 (YTD)-10.38%
Gross Margin (TTM)44.24%
Net Profit Margin (TTM)-6.52%
EPS (TTM)$-0.86
10-Day Avg Trading Volume0.30M
EPS Excl Extra (TTM)$-0.86
Revenue Growth (5Y)2.48%
EPS (Annual)$-0.86
ROI (Annual)-11.83%
Gross Margin (Annual)44.24%
Net Profit Margin (5Y Avg)-14.73%
Cash / Share (Quarterly)$4.39
Revenue Growth QoQ (YoY)2.05%
ROA (Last FY)-7.62%
Revenue Growth TTM (YoY)3.86%
EBITD / Share (TTM)$-0.27
ROE (5Y Avg)-22.47%
Operating Margin (TTM)-8.66%
Cash Flow / Share (Annual)$-0.79
P/B Ratio0.88x
P/B Ratio (Quarterly)0.95x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)0.19x
Net Interest Coverage (TTM)26.25x
ROA (TTM)-7.42%
EV / EBITDA (TTM)15.14x
EPS Incl Extra (Annual)$-0.86
Current Ratio (Annual)3.12x
Quick Ratio (Quarterly)2.51x
3-Month Avg Trading Volume0.25M
52-Week Price Return-15.30%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$5.93
P/S Ratio (Annual)0.48x
Asset Turnover (Annual)1.17x
52-Week High$9.13
Operating Margin (5Y Avg)-15.20%
EPS Excl Extra (Annual)$-0.86
CapEx CAGR (5Y)-10.02%
Tangible BV CAGR (5Y)-10.48%
26-Week Price Return-28.65%
Quick Ratio (Annual)2.51x
13-Week Price Return-0.16%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)3.12x
Enterprise Value$65.112
Revenue / Share Growth (5Y)-1.34%
Asset Turnover (TTM)1.14x
Book Value / Share Growth (5Y)-14.91%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)7.66x
Pretax Margin (Annual)-6.71%
Cash / Share (Annual)$4.39
3-Month Return Std Dev48.67%
Gross Margin (5Y Avg)44.09%
Net Income / Employee (TTM)$-0
ROE (Last FY)-11.83%
Net Interest Coverage (Annual)13.86x
EPS Basic Excl Extra (Annual)$-0.86
P/FCF (TTM)310.37x
Receivables Turnover (TTM)10.19x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.86
Receivables Turnover (Annual)10.19x
ROI (TTM)-11.56%
P/S Ratio (TTM)0.48x
Pretax Margin (5Y Avg)-13.93%
Revenue / Share (Annual)$13.11
Tangible BV / Share (Annual)$5.93
Price vs S&P 500 (52W)-45.13%
Year-to-Date Return-7.74%
5-Day Price Return-6.91%
EPS Normalized (Annual)$-0.86
ROA (5Y Avg)-14.63%
Net Profit Margin (Annual)-6.52%
Month-to-Date Return0.32%
Cash Flow / Share (TTM)$-5.02
EBITD / Share (Annual)$-0.86
Operating Margin (Annual)-8.66%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-22.47%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.86
P/TBV (Quarterly)1.13x
P/B Ratio (Annual)0.95x
Inventory Turnover (TTM)7.66x
Pretax Margin (TTM)-6.71%
Book Value / Share (Annual)$7.06
Price vs S&P 500 (13W)-0.85%
Beta1.60x
P/FCF (Annual)8.70x
Revenue / Share (TTM)$12.83
ROE (TTM)-11.56%
52-Week Low$5.34
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.13
4.13
4.13
4.13
Industry Peers — Orthopedic & Prosthetic Devices(25)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
INGNInogen Inc | 0.48x | 2.48% | 44.24% | -8.66% | $6.59 |
ISRGIntuitive Surgical Inc. | 16.35x | 18.22% | 66.00% | 29.27% | $458.08 |
EWEdwards Lifesciences Corp | 7.42x | 6.70% | 78.01% | 18.41% | $79.05 |
STESTERIS plc | 3.70x | 12.49% | 44.11% | 17.03% | $219.97 |
ZBHZimmer Biomet Holdings, Inc. | 2.28x | 3.22% | 69.71% | 13.34% | $94.78 |
ALGNAlign Technology Inc | 3.29x | 10.30% | 68.27% | 13.53% | $185.02 |
SNNSmith & Nephew plc | 2.36x | 6.21% | 68.01% | 12.88% | $33.83 |
MSAMine Safety Incorporated | 3.40x | 6.82% | 46.46% | 19.83% | $165.17 |
ESTAEstablishment Labs Holdings Inc. | 8.96x | 20.04% | 69.32% | -18.48% | $64.51 |
ENOVEnovis Corporation | 0.65x | -6.05% | 58.16% | -50.09% | $25.20 |
CDRECadre Holdings, Inc. | 2.32x | 8.57% | 42.54% | 11.04% | $30.43 |
About
Inogen Inc develops and manufactures respiratory care products for patients with chronic respiratory conditions, including portable and stationary oxygen concentrators, airway clearance devices, and CPAP masks. The company generates revenue through product sales and equipment rental services across its respiratory health solutions portfolio.